Cargando…
Contribution of microRNA to pathological fibrosis in cardio-renal syndrome: impact of uremic toxins
Progressive reduction in kidney function in patients following myocardial infarction (MI) is associated with an increase in circulating uremic toxins levels leading to increased extracellular matrix deposition. We have recently reported that treatment with uremic toxin adsorbent AST-120 in rats with...
Autores principales: | Rana, Indrajeetsinh, Kompa, Andrew R, Skommer, Joanna, Wang, Bing H, Lekawanvijit, Suree, Kelly, Darren J, Krum, Henry, Charchar, Fadi J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425975/ https://www.ncbi.nlm.nih.gov/pubmed/25896982 http://dx.doi.org/10.14814/phy2.12371 |
Ejemplares similares
-
Contribution of microRNA to pathological fibrosis in cardio-renal syndrome: impact of uremic toxins
por: Rana, Indrajeetsinh, et al.
Publicado: (2015) -
Chronic Kidney Disease-Induced Cardiac Fibrosis Is Ameliorated by Reducing Circulating Levels of a Non-Dialysable Uremic Toxin, Indoxyl Sulfate
por: Lekawanvijit, Suree, et al.
Publicado: (2012) -
The Uremic Toxin Adsorbent AST-120 Abrogates Cardiorenal Injury Following Myocardial Infarction
por: Lekawanvijit, Suree, et al.
Publicado: (2013) -
Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome
por: Lekawanvijit, Suree
Publicado: (2018) -
Small molecules, big effects: the role of microRNAs in regulation of cardiomyocyte death
por: Skommer, J, et al.
Publicado: (2014)